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Introduction
In this prospective study, we compared unilateral and
bilateral thyroarytenoid muscle injections of Botulinum
toxin (Dysport®) in 31 patients with adductor spasmodic
dysphonia, who had undergone more than 5 consecutive
Dysport® injections (either unilateral or bilateral) and had
completed 5 concomitant self-rated efficacy and compli-
cation scores questionnaires related to the previous injec-
tions. We also developed a Neurophysiological Scoring
(NPS) system which has utility in the treatment adminis-
tration.
Materials and methods
Data were gathered prospectively on voice improvement
(self-rated 6 point scale), length of response and duration
of complications (breathiness, cough, dysphagia and total
voice loss). Injections were performed under electromyog-
raphy (EMG) guidance. NPS scale was used to describe the
EMG response. Dose and unilateral/bilateral injections
were determined by clinical judgment based on previous
response. Time intervals between injections were patient
driven.
Results
Low dose unilateral Dysport® injection was associated
with no significant difference in the patient's outcome in
terms of duration of action, voice score and complication
rate when compared to bilateral injections. Unilateral
injections were not associated with any post treatment
total voice loss unlike the bilateral injections.
Conclusion
Unilateral low dose Dysport® injections are recommended
in the treatment of Adductor Spasmodic Dysphonia.
from 1st Scientific Meeting of the Head and Neck Optical Diagnostics Society
London, UK. 14 March 2009
Published: 28 July 2009
Head & Neck Oncology 2009, 1(Suppl 1):P25 doi:10.1186/1758-3284-1-S1-P25
<supplement> <title> <p>1<sup>st </sup>Scientific Meeting of the Head and Neck Optical Diagnostics Society</p> </title> <editor>Colin Hopper, Adel K El-Naggar, Tahwinder Upile, Waseem Jerjes and HJCM Sterenborg</editor> <sponsor> <note>Publication of this supplement was made possible with support from KARL STORZ Endoskope</note> </sponsor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1758-3284-1-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1758-3284-1-S1-info.pdf</url> </supplement>
This abstract is available from: http://www.headandneckoncology.org/content/1/S1/P25
© 2009 Abiola et al; licensee BioMed Central Ltd. 
